CY2020015I1 - Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα - Google Patents

Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα

Info

Publication number: CY2020015I1
Authority: CY; Cyprus
Prior art keywords: ciclesonide; horses; treatment; airway disease; airway
Prior art date: 2012-12-21

Application number

CY2020015C

Other languages

English (en)

Other versions

CY2020015I2 (el

Original Assignee

Boehringer Ingelheim Vetmedica Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-21

Filing date

2020-06-29

Publication date

2020-11-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2020015(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2020-06-29 Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh

2020-11-25 Publication of CY2020015I1 publication Critical patent/CY2020015I1/el

2021-03-12 Publication of CY2020015I2 publication Critical patent/CY2020015I2/el

Links

LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 title 1
229960003728 ciclesonide Drugs 0.000 title 1
208000023504 respiratory system disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system

CY2020015C 2012-12-21 2020-06-29 Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα CY2020015I2 (el)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP12199302		2012-12-21
EP13811924.3A EP2934479B1 (en)	2012-12-21	2013-12-18	Ciclesonide for the treatment of airway disease in horses
PCT/EP2013/077265 WO2014096115A1 (en)	2012-12-21	2013-12-18	Ciclesonide for the treatment of airway disease in horses

Publications (2)

Publication Number	Publication Date
CY2020015I1 true CY2020015I1 (el)	2020-11-25
CY2020015I2 CY2020015I2 (el)	2021-03-12

Family

ID=47552829

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CY181101189T CY1121115T1 (el)	2012-12-21	2018-11-09	Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα
CY2020015C CY2020015I2 (el)	2012-12-21	2020-06-29	Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CY181101189T CY1121115T1 (el)	2012-12-21	2018-11-09	Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα

Country Status (24)

Country	Link
US (4)	US9918995B2 (el)
EP (1)	EP2934479B1 (el)
AR (1)	AR094241A1 (el)
AU (2)	AU2013360691B2 (el)
BR (2)	BR112015010842B1 (el)
CA (1)	CA2888428C (el)
CY (2)	CY1121115T1 (el)
DK (1)	DK2934479T3 (el)
ES (1)	ES2693779T3 (el)
FR (1)	FR20C1026I1 (el)
HR (1)	HRP20181980T1 (el)
HU (1)	HUS2000020I1 (el)
IN (1)	IN2015DN02894A (el)
LT (2)	LT2934479T (el)
MA (1)	MA38169B2 (el)
MX (1)	MX368306B (el)
NO (1)	NO2020014I1 (el)
NZ (1)	NZ706573A (el)
PL (1)	PL2934479T3 (el)
PT (1)	PT2934479T (el)
RS (1)	RS57740B1 (el)
SI (1)	SI2934479T1 (el)
WO (1)	WO2014096115A1 (el)
ZA (1)	ZA201502288B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20140057604A (ko)	2011-08-12	2014-05-13	베링거잉겔하임베트메디카게엠베하	고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
LT3473255T (lt)	2012-12-21	2022-03-10	Boehringer Ingelheim Vetmedica Gmbh	Farmacinė vaisto forma, apimanti ciklezonidą
BR112015010842B1 (pt)	2012-12-21	2021-03-30	Boehringer Ingelheim Vetmedica Gmbh	Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
DK3157522T3 (da)	2014-06-18	2019-12-09	Boehringer Ingelheim Vetmedica Gmbh	Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste
US11191746B2 (en) *	2016-10-14	2021-12-07	Jeju National University Industry-Academic Cooperation Foundation	Composition for inhibiting a growth of cancer stem cells comprising ciclesonide
US20230033224A1 (en) *	2020-01-10	2023-02-02	Boehringer Ingelheim Vetmedica Gmbh	Ciclesonide for ameliorating quality of life (qol) in equines
EP4188327A1 (en)	2020-07-31	2023-06-07	Chemo Research, S.L.	Combination therapy for inhalation administration

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5954049A (en)	1991-10-15	1999-09-21	Trudell Medical Limited	Equine mask with MDI adapter
DE19536902A1 (de)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en)	1996-02-13	1998-10-20	1263152 Ontario Inc.	Nebulizer apparatus and method
US6264923B1 (en) *	1998-05-13	2001-07-24	3M Innovative Properties Company	Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en)	2000-10-14	2004-03-16	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de)	2000-10-14	2002-04-18	Boehringer Ingelheim Pharma	Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de)	2000-12-15	2002-06-20	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en)	2002-05-21	2005-06-14	Trudell Medical International	Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en)	2002-08-17	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co Kg	Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de)	2002-08-17	2004-02-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
WO2004023984A2 (en)	2002-09-13	2004-03-25	Smith C Steven	Novel composition and method for treatment of upper respiratory conditions
AU2004241746A1 (en) *	2003-05-22	2004-12-02	Nycomed Gmbh	Salmeterol and ciclesonide combination
US20050020692A1 (en)	2003-07-24	2005-01-27	Ciofalo Vincent B.	Treatment of heaves
PL1670482T5 (pl)	2003-09-16	2022-10-03	Covis Pharma Gmbh	Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
PE20050941A1 (es) *	2003-12-16	2005-11-08	Nycomed Gmbh	Suspensiones acuosas de ciclesonida para nebulizacion
EP1740188A1 (en)	2004-04-20	2007-01-10	Altana Pharma AG	Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1763344A1 (en)	2004-06-29	2007-03-21	Boehringer Ingelheim International GmbH	Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de)	2004-11-23	2006-05-24	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es)	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es)	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de agonistas beta
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
NZ596456A (en)	2009-06-25	2014-01-31	Boehringer Ingelheim Vetmed	Inhaler
US7829748B1 (en) *	2009-09-21	2010-11-09	Honeywell International Inc.	Process for the manufacture of 1,3,3,3-tetrafluoropropene
WO2014007766A1 (en)	2012-07-05	2014-01-09	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Dry powder inhalers comprising a carrier other than lactose
EA201590030A1 (ru)	2012-07-05	2015-09-30	Арвен Айлак Санайи Ве Тиджарет А.С.	Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
US9539408B2 (en)	2012-10-31	2017-01-10	Trudell Medical International	Nebulizer apparatus
BR112015010842B1 (pt)	2012-12-21	2021-03-30	Boehringer Ingelheim Vetmedica Gmbh	Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
LT3473255T (lt)	2012-12-21	2022-03-10	Boehringer Ingelheim Vetmedica Gmbh	Farmacinė vaisto forma, apimanti ciklezonidą
PL3035886T3 (pl)	2013-08-20	2021-05-31	Boehringer Ingelheim Vetmedica Gmbh	Inhalator
EP3035885B1 (en)	2013-08-20	2019-12-25	Boehringer Ingelheim Vetmedica GmbH	Inhaler
DK3157522T3 (da)	2014-06-18	2019-12-09	Boehringer Ingelheim Vetmedica Gmbh	Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste

2013
- 2013-12-18 BR BR112015010842-3A patent/BR112015010842B1/pt active IP Right Grant
- 2013-12-18 CA CA2888428A patent/CA2888428C/en active Active
- 2013-12-18 NZ NZ70657313A patent/NZ706573A/en unknown
- 2013-12-18 PT PT13811924T patent/PT2934479T/pt unknown
- 2013-12-18 IN IN2894DEN2015 patent/IN2015DN02894A/en unknown
- 2013-12-18 MX MX2015007947A patent/MX368306B/es active IP Right Grant
- 2013-12-18 PL PL13811924T patent/PL2934479T3/pl unknown
- 2013-12-18 AU AU2013360691A patent/AU2013360691B2/en active Active
- 2013-12-18 US US14/654,009 patent/US9918995B2/en active Active
- 2013-12-18 US US14/132,580 patent/US20140179651A1/en not_active Abandoned
- 2013-12-18 WO PCT/EP2013/077265 patent/WO2014096115A1/en active Application Filing
- 2013-12-18 SI SI201331266T patent/SI2934479T1/sl unknown
- 2013-12-18 DK DK13811924.3T patent/DK2934479T3/en active
- 2013-12-18 RS RS20181190A patent/RS57740B1/sr unknown
- 2013-12-18 LT LTEP13811924.3T patent/LT2934479T/lt unknown
- 2013-12-18 ES ES13811924.3T patent/ES2693779T3/es active Active
- 2013-12-18 BR BR122016029247-9A patent/BR122016029247A2/pt not_active Application Discontinuation
- 2013-12-18 MA MA38169A patent/MA38169B2/fr unknown
- 2013-12-18 EP EP13811924.3A patent/EP2934479B1/en active Active
- 2013-12-20 AR ARP130104978A patent/AR094241A1/es not_active Application Discontinuation
2015
- 2015-04-07 ZA ZA2015/02288A patent/ZA201502288B/en unknown
2016
- 2016-10-13 US US15/292,765 patent/US10258634B2/en active Active
2018
- 2018-02-06 US US15/889,307 patent/US10441597B2/en active Active
- 2018-03-07 AU AU2018201642A patent/AU2018201642B2/en active Active
- 2018-11-09 CY CY181101189T patent/CY1121115T1/el unknown
- 2018-11-26 HR HRP20181980TT patent/HRP20181980T1/hr unknown
2020
- 2020-06-12 NO NO2020014C patent/NO2020014I1/no unknown
- 2020-06-18 LT LTPA2020511C patent/LTPA2020511I1/lt unknown
- 2020-06-26 FR FR20C1026C patent/FR20C1026I1/fr active Active
- 2020-06-29 CY CY2020015C patent/CY2020015I2/el unknown
- 2020-06-29 HU HUS2000020C patent/HUS2000020I1/hu unknown

Also Published As

Publication number	Publication date
AU2013360691A1 (en)	2015-04-16
HUS2000020I1 (hu)	2020-07-28
CA2888428A1 (en)	2014-06-26
US20180153907A1 (en)	2018-06-07
US20140179651A1 (en)	2014-06-26
ES2693779T3 (es)	2018-12-13
NZ706573A (en)	2019-11-29
US20150313918A1 (en)	2015-11-05
AU2018201642B2 (en)	2019-01-31
DK2934479T3 (en)	2018-11-05
MX368306B (es)	2019-09-27
SI2934479T1 (sl)	2019-01-31
US10258634B2 (en)	2019-04-16
AU2013360691B2 (en)	2018-03-08
MA38169B2 (fr)	2021-08-31
LTPA2020511I1 (lt)	2020-07-27
LT2934479T (lt)	2018-12-27
AR094241A1 (es)	2015-07-22
US9918995B2 (en)	2018-03-20
EP2934479A1 (en)	2015-10-28
ZA201502288B (en)	2019-09-25
AU2018201642A1 (en)	2018-03-29
US20170079988A1 (en)	2017-03-23
FR20C1026I1 (fr)	2020-10-02
CA2888428C (en)	2021-07-13
IN2015DN02894A (el)	2015-09-11
BR112015010842B1 (pt)	2021-03-30
CY2020015I2 (el)	2021-03-12
BR112015010842A8 (pt)	2019-10-01
HRP20181980T1 (hr)	2019-01-25
RS57740B1 (sr)	2018-12-31
US10441597B2 (en)	2019-10-15
MA38169A1 (fr)	2017-01-31
PL2934479T3 (pl)	2019-02-28
NO2020014I1 (no)	2020-06-12
PT2934479T (pt)	2018-12-20
MX2015007947A (es)	2015-10-08
BR112015010842A2 (pt)	2017-07-11
BR122016029247A2 (pt)	2019-08-20
CY1121115T1 (el)	2019-12-11
WO2014096115A1 (en)	2014-06-26
EP2934479B1 (en)	2018-09-19

Publication	Publication Date	Title
LTPA2020510I1 (lt)	2020-07-10	Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui
CY2020015I2 (el)	2021-03-12	Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα
HK1200872A1 (en)	2015-08-14	Animal models and therapeutic molecules
DK2919796T3 (da)	2021-05-31	Brug af akkermansia til behandling af stofskiftesygdomme
DK2863990T3 (da)	2017-11-20	Medicinsk mikroelektrode
DK3335652T3 (da)	2020-07-27	Medicinsk fastgørelseselement
DK2760886T3 (da)	2019-12-09	Immunocytokin-kombinationsterapi
FI20115876A0 (fi)	2011-09-06	Yhdistelmähoito
UA24447S (uk)	2013-03-11	М'ясорубка
BR112014009789A2 (pt)	2017-04-25	cisteamina no tratamento da doença fibrótica
BR112014026557A2 (pt)	2017-10-24	fralda descartável.
FI20135231A (fi)	2014-09-12	Potilasalusta
BR112014026553A2 (pt)	2017-10-03	Fralda descartável
BR112014005362A2 (pt)	2017-06-13	vacinas de tumor com nanopartículas
CO6880064A2 (es)	2014-02-28	Métodos terapéuticos
BR112014030277A2 (pt)	2017-06-27	sistema médico
SMT201700103B (it)	2017-03-08	Bersaglio terapeutico e diagnostico
CO7091176A2 (es)	2014-10-21	Diagnóstico farmacéutico
ITRM20120530A1 (it)	2014-05-01	Compounds for use in the treatment of parasitic diseases
HK1211790A1 (en)	2016-06-03	Animal model of krabbes disease
JP2014529605A5 (ja)	2015-02-26	血管形成関連性疾患を治療するためのｎｃ−１を含むタンパク質
FI20115640A0 (fi)	2011-06-22	Yhdistelmähoito
DK2694056T3 (da)	2020-01-02	Terapeutisk behandling
FI20116047L (fi)	2013-04-25	Menetelmä terveyskortin hallinnoimiseksi
TH148778B (th)	2016-04-18	เปปไทด์รักษาโรค